| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1056/NEJMRA1504367 |
| P698 | PubMed publication ID | 27557303 |
| P2093 | author name string | Bruce A Runyon | |
| Phillip S Ge | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 767-777 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Treatment of Patients with Cirrhosis. | |
| P478 | volume | 375 |
| Q37593985 | Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases |
| Q39404643 | Adipokines in Liver Cirrhosis |
| Q46754211 | African-Americans with Cirrhosis Are Less Likely to Receive Endoscopic Variceal Screening Within One Year of Cirrhosis Diagnosis |
| Q40045308 | Albumin Prevents Infections in Patients with Chronic Liver Failure in a Single-arm Feasibility Trial |
| Q90988810 | Alcoholic liver disease |
| Q64978766 | Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function. |
| Q39323841 | Ascites, refractory ascites and hyponatremia in cirrhosis |
| Q88242993 | Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia |
| Q33582978 | Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C |
| Q37544826 | Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell |
| Q90321255 | Bacterial Infections in Patients with Liver Cirrhosis in an Internal Medicine Department |
| Q48027127 | Circulating fibroblast growth factor 21 in patients with liver cirrhosis |
| Q46270707 | Cirrhosis and LI-RADS. |
| Q64062144 | Clinical efficacy of octreotide acetate combined with thrombin in the treatment of liver cirrhosis complicated with gastrointestinal hemorrhage |
| Q64093529 | Current and future pharmacological therapies for managing cirrhosis and its complications |
| Q39151677 | Current therapy for chronic hepatitis C: The role of direct-acting antivirals |
| Q55376294 | Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients. |
| Q38655765 | Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis |
| Q89704751 | Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients |
| Q47705540 | Fluid balance concepts in medicine: Principles and practice |
| Q51743701 | Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer. |
| Q40200602 | Hepatic stellate cells as key target in liver fibrosis |
| Q49305575 | High CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines |
| Q92102382 | Isolated Penile Edema After Diagnostic Paracentesis |
| Q57216494 | Liver cirrhosis and cancer: comparison of mortality |
| Q57824692 | Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure |
| Q99609304 | Mitochondrial dysfunction in fibrotic diseases |
| Q53686281 | Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites. |
| Q91940609 | Observational study of the microcirculation in patients with liver cirrhosis |
| Q48533165 | Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study |
| Q41042331 | Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients |
| Q47563178 | Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection. |
| Q48175320 | Prognostic impact and risk factors of low body mass index in patients undergoing liver transplantation. |
| Q39139047 | Protein Requirements for Critically Ill Patients With Renal and Liver Failure |
| Q47147228 | Quantification of ascites based on abdomino-pelvic computed tomography scans for predicting the in-hospital mortality of liver cirrhosis |
| Q57489097 | Radiation-Induced Liver Disease and Modern Radiotherapy |
| Q89938906 | Rebleeding in Variceal and Nonvariceal Gastrointestinal Bleeds in Cirrhotic Patients Using Vitamin K1: The LIVER-K Study |
| Q92661408 | Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs |
| Q64072117 | Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets |
| Q47812599 | Review article: the role of the microcirculation in liver cirrhosis |
| Q60046370 | Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy |
| Q89976405 | Serum Zinc Level Grading System: A Useful Model for Composite Hepatic Events in Hepatitis C Virus-Associated Liver Cirrhosis |
| Q47372528 | TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse. |
| Q92308045 | The Effect of Vascular Endothelial Growth Factor on Bone Marrow Mesenchymal Stem Cell Engraftment in Rat Fibrotic Liver upon Transplantation |
| Q91841670 | The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis |
| Q92937609 | The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 |
| Q90420440 | Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis |
| Q92615769 | Usefulness of autotaxin for the complications of liver cirrhosis |
| Q103805824 | Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure |
| Q91461372 | Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic Patients: A Model Based on the Administrative Database |
| Q47291117 | Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis |
Search more.